Oral administration of Bifidobacterium spp. improves insulin resistance, induces adiponectin, and prevents inflammatory adipokine expressions

Biomedical Research (Japan)

Volumn 35, Issue 5, 2014, Pages 303-310

  Le, Thi Kim Chung ^a   Hosaka, Toshio ^b   Le, Thi Thanh Tam ^c   Nguyen, Thi Giang ^a   Tran, Quang Binh ^d   Le, Thi Hong Hao ^a   Da Pham, Xuan ^a  

^a National Institute for Food Control   (Viet Nam)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Plant Protection Research Institute   (Viet Nam)

^d NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROBIOTIC AGENT; ADIPOCYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; CONTROLLED STUDY; DRUG EFFECT; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN EXPRESSION; PROTEIN INDUCTION; ANIMAL; BIFIDOBACTERIUM; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE TOLERANCE TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADIPOKINES; ADIPONECTIN; ADMINISTRATION, ORAL; ANIMALS; BIFIDOBACTERIUM; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; INTERLEUKIN-6; MALE; MICE; RNA, MESSENGER;

EID: 84908646792     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.35.303     Document Type: Article

References (29)

1. Andrikopoulos S, Blair AR, Deluca N, Fam BC and Proietto J (2008) Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 295, E1323-1332.
2. Antuna-Puente B, Feve B, Fellahi S and Bastard JP (2007) Obesity, inflammation and insulin resistance: which role for adipokines. Therapie 62, 285-292.
3. Awazawa M, Ueki K, Inabe K, Yamauchi T, Kubota N, Kaneko K, Kobayashi M, Iwane A, Sasako T, Okazaki Y, Ohsugi M, Takamoto I, Yamashita S, Asahara H, Akira S, Kasuga M, Kadowaki T (2011) Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 13, 401-12.
4. D'Aimmo MR, Modesto M and Biavati B (2007) Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products. Int J Food Microbiol 115, 35-42.
5. De Man JD, Rogosa M, and Sharpe ME (1960) A medium for the cultivation of Lactobacilli. J Appl Bact 23, 130-5.
6. Fantuzzi G and Mazzone T (2007) Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol 27, 996-1003.
7. Fasshauer M, Klein J, Neumann S, Eszlinger M and Paschke R (2001) Adiponectin gene expression is inhibited by betaadrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 507, 142-146.
8. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J and Paschke R (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301, 1045-1050.
9. Ganguli K, Meng D, Rautava S, Lu L, Walker WA and Nanthakumar N (2013) Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol 304, G132-G141.
10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T and Matsuzawa Y (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20, 1595-1599.
11. Hu E, Liang P and Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271, 10697-10703.
12. Kadowaki T and Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26, 439-451.
13. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R, Kitazawa S, Miyachi H, Maeda S, Egashira K and Kasuga M (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494-1505.
14. Kern PA, Ranganathan S, Li C, Wood L and Ranganathan G (2001) Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280, E745-751.
15. high T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation. Clin Immunol 123, 30-39.
16. Klover PJ, Zimmers TA, Koniaris LG and Mooney RA (2003) Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52, 2784-2789.
17. Lee K, Paek K, Lee HY, Park JH and Lee Y (2007) Antiobesity effect of trans-10, cis-12-conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. J Appl Microbiol 103, 1140-1146.
18. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, Desimone C, Song XY and Diehl AM (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37, 343-350.
19. Ma X, Hua J and Li Z (2008) Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49, 821-830.
20. Naito E, Yoshida Y, Makino K, Kounoshi Y, Kunihiro S, Takahashi R, Matsuzaki T, Miyazaki K and Ishikawa F (2011) Beneficial effect of oral administration of Lactobacillus casei strain Shirota on insulin resistance in diet-induced obesity mice. J Appl Microbiol 110, 650-657.
21. Pickup JC, Mattock MB, Chusney GD and Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40, 1286-1292.
22. Roselli M, Finamore A, Nuccitelli S, Carnevali P, Brigidi P, Vitali B, Nobili F, Rami R, Garaguso I and Mengheri E (2009) Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of γδT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis 15, 1526-1536.
23. Rotter V, Nagaev I and Smith U (2003) Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278, 45777-45784.
24. Senn JJ, Klover PJ, Nowak IA and Mooney RA (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51, 3391-3399.
25. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87, 4-14.
26. Tomosada Y, Villena J, Murata K, Chiba E, Shimazu T, Aso H, Iwabuchi N, Xiao JZ, Saito T and Kitazawa H (2013) Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS One 8, e59259.
27. Weinger K, Beverly EA and Smaldone A (2014) Diabetes self-care and the older adult. West J Nurs Res [Epub ahead of print].
28. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE and Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935.
29. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB and Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295.